Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

March 31, 2025

Conditions
Prodromal Alzheimer's DiseaseCerebral Vascular DisorderMild Cognitive ImpairmentVascular Cognitive Impairment
Interventions
DEVICE

Hyperbaric oxygen therapy

Each session will include exposure of 90 minutes to 100% at 2 ATA, with 5 minutes air breaks every 20 minutes

DEVICE

Sham

Each session will include exposure of 90 minutes to 21% at 1.2 ATA during the first five minutes of the session with the noise of circulating air, and then decrease slowly during the next five minutes to 1.03 ATA

Trial Locations (1)

70300

RECRUITING

Shamir Medical Center (Assaf Harofeh), Ẕerifin

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV